STOCK TITAN

Vor Biopharma: Chen Yu reports 9.2% ownership

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Vor Biopharma Inc. (VOR) is the subject of an amended Schedule 13G in which TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P. report beneficial ownership of its common stock. Each fund reports 2,836,539 shares, or 4.6%, with shared voting and dispositive power; TCG Crossover GP II, LLC and TCG Crossover GP III, LLC report power over those same fund-held blocks. Chen Yu, sole managing member of both general partners, reports shared voting and dispositive power over 5,673,078 shares, or 9.2%, comprising the two fund-held blocks. The percentages are based on 61,434,344 shares outstanding as of October 26, 2026. The reporting persons state that they do not constitute a group and disclaim beneficial ownership except as described in the amendment and to the extent of their pecuniary interest.

Shares reported by each fund 2,836,539 shares Each of TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P. reports this amount.
Class ownership reported by each fund 4.6% Reported for each fund-held block.
Shares reported by Chen Yu 5,673,078 shares Reported with shared voting and dispositive power; consists of the two fund-held blocks.
Class ownership reported by Chen Yu 9.2% Based on 61,434,344 common shares outstanding as of October 26, 2026.
Common shares outstanding 61,434,344 shares As of October 26, 2026; basis for the reported ownership percentages.
beneficial ownership regulatory
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power 2,836,539.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 2,836,539.00"
pecuniary interest financial
"except to the extent of such Reporting Person's pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VOR shares does Chen Yu report beneficial ownership of?

Chen Yu reports beneficial ownership of 5,673,078 shares, or 9.2% of the class. The amount consists of 2,836,539 shares held by each of TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





929033207

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: These securities are held of record by TCG Crossover II (as defined in Item 2(a) below). TCG Crossover GP II (as defined in Item 2(a) below) is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 61,434,344 shares of Common Stock outstanding as of October 26, 2026, as reported by the Issuer (as defined in Item 1(a) below) in its quarterly report filed with the United States Securities and Exchange Commission (the Commission) on October 30, 2026 (the Form 10-Q).


SCHEDULE 13G




Comment for Type of Reporting Person: These securities are held of record by TCG Crossover II. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 61,434,344 shares of Common Stock outstanding as of October 26, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: These securities are held of record by TCG Crossover III (as defined in Item 2(a) below). TCG Crossover GP III (as defined in Item 2(a) below) is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 61,434,344 shares of Common Stock outstanding as of October 26, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: These securities are held of record by TCG Crossover III. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 61,434,344 shares of Common Stock outstanding as of October 26, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 2,836,539 shares of Common Stock held of record by TCG Crossover II and (ii) 2,836,539 shares of Common Stock held of record by TCG Crossover III. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover II. TCG Crossover GP III is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to the securities held of record by TCG Crossover III. Chen Yu is the sole managing member of each of TCG Crossover GP II and TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to the securities held of record by TCG Crossover II and TCG Crossover III. Based on 61,434,344 shares of Common Stock outstanding as of October 26, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G



TCG Crossover GP II, LLC
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
TCG Crossover Fund II, L.P.
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
TCG Crossover GP III, LLC
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
TCG Crossover Fund III, L.P.
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
Chen Yu
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, as Attorney-in-Fact for Chen Yu
Date:11/16/2026

Keep reading